Security Interest

Recorded: 2003-10-08 Received: 2004-06-03 Pages: 115

Assignor

AMYLIN PHARMACEUTICALS, INC.

Executed: 2003-06-30

Assignee

ELI LILLY AND COMPANY

LILLY CORPORATE CENTER, INDIANAPOLIS, IN, 46285, UNITED STATES

Covered Properties (3)

Novel Exendin Agonist Formulations and Methods of Administration Thereof

Application: 09/889,330 →

Methods for Glucagon Suppression

Application: 09/889,331 →

Use of exendins and agonists thereof for modulation of triglyceride levels and treatment of dyslipidemia

Application: 09/756,690 →